\[S,S\]-Reboxetine will be used to evaluate pharmacodynamic changes in urethral function in healthy volunteers using a novel methodology
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
12
Pfizer Investigational Site
Hellerup, Denmark
Reflectometry measurements at visit 2, 3, 4 , 5, 6 and 7.
Urethral pressure profile measurements at visit 2, 3, 4, 5, 6 and 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.